跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达伯坦 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pemigatinib Tablets
Approved
化学药品
Pemigatinib Tablets
Incyte Biosciences Distribution B.V.
🇨🇳 National Medical Products Administration
Approval Date
Mar 29, 2022
Approval ID
8FPocQQNEdF
Company
Incyte Biosciences Distribution B.V.
Type
化学药品
Approval Details
Approval Id
8FPocQQNEdF
Approval Number
国药准字HJ20220027
Generic Name
佩米替尼片
Generic Name En
Pemigatinib Tablets
Trade Name
达伯坦
Drug Type
化学药品
Dosage Form
片剂
Strength
4.5mg
Reg Date
2022-03-29
Expired Date
2027-03-28
Company Name
Incyte Biosciences Distribution B.V.
Production Company Name
Lonza Tampa Llc
Company Detail Path
/organization/incyte-biosciences-distribution-b-v
Production Company Detail Path
/organization/lonza-tampa-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 29, 2022
Approval ID
8FPocQQNEdF
Type
化学药品
Back to NMPA Approvals